Siemens Healthcare has received U.S. Food and Drug Administration (FDA) clearance for two new MR postprocessing software applications.
The agency approved syngo.MR OncoCare for oncology and syngo.MR Neuro Dynamics for neurology on August 7, according to MR product manager Anne Sheehan. The packages have already been released outside of the U.S.
Syngo.MR OncoCare is compatible with all Siemens MR systems and can be used on every body part, ranging from the brain to the liver, and syngo.MR Neuro Dynamics allows radiologists to better assess tumors in the brain by evaluating the blood flows of those tumors, Sheehan told AuntMinnie.com.
